Skip to main content
Skip to section navigation
Skip to footer
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.
NASDAQ:LEXX; NASDAQ WARRANT:LEXXW
Toggle menu
Home
About
Management
Board of Directors
Advisors & Consultants
Technology
Overview
Commercial Applications
Research
Patent Portfolio
Licensing Opportunities
Investors
Contact
Section 16 Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Presentations
Company Info
Overview
Management Team
Contacts
2024 Annual General Meeting
2023 Special Meeting
FAQ
Analyst Coverage
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
SEDAR+
Legend Removal
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
3
4
4/A
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
Date
Form
Description
PDF
XBRL
Pages
07/14/06
3
Initial statement of beneficial ownership of securities
1
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
32
Page
33
Page
34
Page
35
Page
36
Page
37
Page
38
Page
39
Page
40
Page
41
Email Alerts
Contacts
RSS News Feed
Back to the top